Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HIV
Biotech
Merck wades deeper into HIV PrEP waters with pair of trials
The New Jersey pharma is teaming up with the Gates Foundation to launch a pair of phase 3 trials of its once-monthly, oral PrEP prospect.
Darren Incorvaia
Jul 14, 2025 1:12pm
Fierce Healthcare
Judge sides with states, blocking HHS reorg and mass layoffs
Jul 1, 2025 3:30pm
FDA slaps clinical hold on multiple Gilead HIV trials
Jun 10, 2025 10:48am
Gilead pays partner Hookipa $10M for HBV, HIV vaccines
May 22, 2025 10:10am
GSK posts data on HIV assets vying for roles in 6-month combo
Mar 12, 2025 11:25am
Immunocore bispecific reduces HIV reservoir in early trial
Mar 10, 2025 3:00pm